-
2
-
-
3543139950
-
-
Chinese source
-
Chinese source. 2003, 7(25):3532-3
-
(2003)
, vol.7
, Issue.25
, pp. 3532-3533
-
-
-
3
-
-
0032842283
-
Diabetic neuropathy: Pathogenesis and therapy
-
Vinik AI. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999; 107 (2B):17S-26S
-
(1999)
Am. J. Med.
, vol.107
, Issue.2 B
-
-
Vinik, A.I.1
-
4
-
-
3543087260
-
-
Chinese source
-
Chinese source. 2003,7(17):2393
-
(2003)
, vol.7
, Issue.17
, pp. 2393
-
-
-
5
-
-
3543118802
-
-
Chinese source
-
Chinese source. 2003,7 (27):3766
-
(2003)
, vol.7
, Issue.27
, pp. 3766
-
-
-
6
-
-
3543145895
-
-
Chinese source
-
Chinese source. 2003, 7(1): 111
-
(2003)
, vol.7
, Issue.1
, pp. 111
-
-
-
7
-
-
0030923990
-
Metabolic and vascular factors in the pathogenesis of diabetic neuropathy
-
Cameron NE, Cotter MA. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 1997; 46 Suppl 2: S31-7
-
(1997)
Diabetes
, vol.46
, Issue.SUPPL. 2
-
-
Cameron, N.E.1
Cotter, M.A.2
-
8
-
-
0030964550
-
The pathology of human diabetic neuropathy
-
Malik RA. The pathology of human diabetic neuropathy. Diabetes 1997; 46 Suppl: 2: S50-3
-
(1997)
Diabetes
, vol.46
, Issue.SUPPL. 2
-
-
Malik, R.A.1
-
9
-
-
0032968970
-
Cilostazol
-
discussion 72-73
-
Sorkin EM, Markham A. Cilostazol. Drugs Aging 1999; 14 (1): 63-71; discussion 72-3
-
(1999)
Drugs Aging
, vol.14
, Issue.1
, pp. 63-71
-
-
Sorkin, E.M.1
Markham, A.2
-
10
-
-
1442319158
-
The pharmacology of cilostazol
-
Schror K. The pharmacology of cilostazol. Diabetes Obes Metab 2002; 4(Suppl 2) S14-9
-
(2002)
Diabetes Obes. Metab.
, vol.4
, Issue.SUPPL. 2
-
-
Schror, K.1
-
11
-
-
0023931294
-
Detection, characterization, and staging of polyneuropathy: Assessed in diabetics
-
Dyck PJ. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988; 11 (1): 21-32
-
(1988)
Muscle Nerve
, vol.11
, Issue.1
, pp. 21-32
-
-
Dyck, P.J.1
-
12
-
-
0036267007
-
Thrombomodulin deficiency in human diabetic nerve micruvasculature
-
Hafer-Macko CE, Ivey FM, Gyure KA, et al. Thrombomodulin deficiency in human diabetic nerve micruvasculature. Diabetes 2002; 51 (6): 1957-63
-
(2002)
Diabetes
, vol.51
, Issue.6
, pp. 1957-1963
-
-
Hafer-Macko, C.E.1
Ivey, F.M.2
Gyure, K.A.3
-
13
-
-
0033159239
-
Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats
-
Suh KS, Oh SJ, Woo JT, et al. Effect of cilostazol on the neuropathies of streptozotocin-induced diabetic rats. Korean J Inter Med 1999; 14 (2): 34-40
-
(1999)
Korean J. Inter. Med.
, vol.14
, Issue.2
, pp. 34-40
-
-
Suh, K.S.1
Oh, S.J.2
Woo, J.T.3
-
14
-
-
0036825970
-
Effects of cilostazol, a selective cycle AMP phosphodiesterase inhibitor on isolated rabbit spinal arterioles
-
Yashiro Y, Ohhashi T. Effects of cilostazol, a selective cycle AMP phosphodiesterase inhibitor on isolated rabbit spinal arterioles. Jpn J Physiol 2002; 52(5): 471-7
-
(2002)
Jpn. J. Physiol.
, vol.52
, Issue.5
, pp. 471-477
-
-
Yashiro, Y.1
Ohhashi, T.2
-
15
-
-
0034560188
-
Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats
-
Yamamoto Y, Yasuda Y, Komiya Y. Cilostazol prevents impairment of slow axonal transport in streptozotocin-diabetic rats. Eur J Pharmacol 2000; 409 (1): 1-7
-
(2000)
Eur. J. Pharmacol.
, vol.409
, Issue.1
, pp. 1-7
-
-
Yamamoto, Y.1
Yasuda, Y.2
Komiya, Y.3
-
16
-
-
0033588432
-
Cilostazol, a cycle AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells
-
Inada H, Shindo H, Tawata M, et al. Cilostazol, a cycle AMP phosphodiesterase inhibitor, stimulates nitric oxide production and sodium potassium adenosine triphosphatase activity in SH-SY5Y human neuroblastoma cells. Life Sci 1999; 65(13):1413-22
-
(1999)
Life Sci.
, vol.65
, Issue.13
, pp. 1413-1422
-
-
Inada, H.1
Shindo, H.2
Tawata, M.3
|